Hoau‐Yan Wang

714 total citations
9 papers, 578 citations indexed

About

Hoau‐Yan Wang is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Hoau‐Yan Wang has authored 9 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Physiology. Recurrent topics in Hoau‐Yan Wang's work include Cholinesterase and Neurodegenerative Diseases (4 papers), Nicotinic Acetylcholine Receptors Study (4 papers) and Alzheimer's disease research and treatments (4 papers). Hoau‐Yan Wang is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (4 papers), Nicotinic Acetylcholine Receptors Study (4 papers) and Alzheimer's disease research and treatments (4 papers). Hoau‐Yan Wang collaborates with scholars based in United States. Hoau‐Yan Wang's co-authors include Daniel H. S. Lee, Richard P. Shank, Lindsay H. Burns, Zhe Pei, Steven E. Arnold, Julie A. Schneider, Ana W. Capuano, Rexford S. Ahima, Zoe Arvanitakis and Bouchra Taïb and has published in prestigious journals such as Annals of Neurology, Journal of Neurochemistry and Alzheimer s & Dementia.

In The Last Decade

Hoau‐Yan Wang

9 papers receiving 571 citations

Peers

Hoau‐Yan Wang

MB

PHYSI

PHARM

CMN

CTM

Lauren G. Friedman United States

Zuolei Xie China

Emeline Keller France

Marta Rodrı́guez Spain

Hui-Fang Li Taiwan

N.K. Robakis United States

Yoshihiro Kumagae Japan

Csaba Kónya Hungary

R. Ravid Sweden

Babak Sabermarouf Iran

Lauren G. Friedman United States

Hoau‐Yan Wang

260 ×0.7

MB

221 ×0.7

PHYSI

126 ×0.5

PHARM

161 ×0.8

CMN

44 ×0.7

CTM

Citations per year, relative to Hoau‐Yan Wang Hoau‐Yan Wang (= 1×) peers Lauren G. Friedman

Countries citing papers authored by Hoau‐Yan Wang

Since Specialization

Citations

This map shows the geographic impact of Hoau‐Yan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hoau‐Yan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hoau‐Yan Wang more than expected).

Fields of papers citing papers by Hoau‐Yan Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hoau‐Yan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hoau‐Yan Wang. The network helps show where Hoau‐Yan Wang may publish in the future.

Co-authorship network of co-authors of Hoau‐Yan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hoau‐Yan Wang. A scholar is included among the top collaborators of Hoau‐Yan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hoau‐Yan Wang. Hoau‐Yan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Burns, Lindsay H., Zhe Pei, & Hoau‐Yan Wang. (2023). Targeting α7 nicotinic acetylcholine receptors and their protein interactions in Alzheimer's disease drug development. Drug Development Research. 84(6). 1085–1095. 26 indexed citations

2.

Wang, Hoau‐Yan, et al.. (2021). SavaDx, a novel plasma biomarker to detect Alzheimer’s disease, confirms mechanism of action of simufilam. Alzheimer s & Dementia. 17(S5). 2 indexed citations

3.

Talbot, Konrad & Hoau‐Yan Wang. (2020). Developing CNS therapeutics for brain insulin resistance in Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Alzheimer s & Dementia. 16(S3). 1 indexed citations

4.

Arvanitakis, Zoe, Hoau‐Yan Wang, Ana W. Capuano, et al.. (2020). Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function. Annals of Neurology. 88(3). 513–525. 78 indexed citations

5.

Talbot, Konrad, Hoau‐Yan Wang, Kalindi Bakshi, John Q. Trojanowski, & Steven E. Arnold. (2011). P4‐441: The diabetes drug liraglutide ameliorates insulin resistance in the hippocampal formation of Alzheimer's disease (AD) cases. Alzheimer s & Dementia. 7(4S_Part_25). 7 indexed citations

6.

Wang, Hoau‐Yan & Lindsay H. Burns. (2006). Gβγ that interacts with adenylyl cyclase in opioid tolerance originates from a Gs protein. Journal of Neurobiology. 66(12). 1302–1310. 39 indexed citations

7.

Lee, Daniel H. S. & Hoau‐Yan Wang. (2003). Differential physiologic responses of α7 nicotinic acetylcholine receptors to β‐amyloid_1–40 and β‐amyloid_1–42. Journal of Neurobiology. 55(1). 25–30. 55 indexed citations

8.

D’Andrea, Michael R., Daniel H. S. Lee, Hoau‐Yan Wang, & Robert G. Nagele. (2002). Targeting intracellular Aβ42 for Alzheimer's disease drug discovery. Drug Development Research. 56(2). 194–200. 9 indexed citations

9.

Wang, Hoau‐Yan, et al.. (2000). Amyloid Peptide Aβ_1‐42 Binds Selectively and with Picomolar Affinity to α7 Nicotinic Acetylcholine Receptors. Journal of Neurochemistry. 75(3). 1155–1161. 361 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact